Table 5.
HRs and 95%CIs of miRNA-15a downregulation in human cancers based on Kaplan-Meier plotter database.
| Cancer types | Sample size | HR (95% CI) | P-value |
|---|---|---|---|
| Human cancers | 7385 | 1.17 (0.95-1.44) | 0.150 |
| BLCA | 408 | 1.49 (1.11-2.00) | 0.0081 |
| BRCA | 1076 | 0.83 (0.58-1.16) | 0.27 |
| CSCC | 307 | 0.55 (0.32-0.93) | 0.026 |
| ESCA | 184 | 0.53 (0.34-0.85) | 0.0072 |
| HNSC | 522 | 1.43 (1.04-1.96) | 0.027 |
| KIRC | 516 | 0.78 (0.55-1.09) | 0.14 |
| KIRP | 290 | 1.59 (0.84-3.03) | 0.15 |
| LIHC | 371 | 1.54 (1.08-2.22) | 0.017 |
| LUAD | 504 | 1.23 (0.92-1.67) | 0.16 |
| LUSC | 472 | 1.69 (1.22-2.38) | 0.0014 |
| OC | 485 | 0.82 (0.65-1.04) | 0.10 |
| PAAD | 178 | 2.22 (1.43-3.45) | 0.0002 |
| PCPG | 179 | 0.14 (0.02-1.20) | 0.038 |
| READ | 160 | 2.63 (1.19-5.88) | 0.013 |
| SARC | 259 | 0.69 (0.46-1.04) | 0.075 |
| STAD | 431 | 1.52 (1.10-2.08) | 0.011 |
| THCA | 506 | 4.17 (0.54-33.33) | 0.140 |
| UCEC | 537 | 1.69 (1.10-2.63) | 0.015 |
BLCA, bladder Carcinoma; BRCA, breast cancer; CSCC, cervical squamous cell carcinoma; ESCA, esophageal carcinoma; HNSC, head-neck squamous cell carcinoma; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OC, ovarian cancer; PAAD, pancreatic ductal adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; READ, rectum adenocarcinoma; SARC, sarcoma; STAD, stomach adenocarcinoma; THCA, thyroid carcinoma; UCEC, uterine corpus endometrial carcinoma.